Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 1, 1999

View Archived Issues

Medigene Licenses Drug To Complement Work In HPV

Xenova Gets OK To Start U.S. Trial Of Cancer Drug

Other News To Note

Peptide's Study Of Product For Hay Fever Falls Short

Germans Discover Gene With Implications In Reproduction

European Commission Tries To Get Handle On GMO Issue

French Start-Up EntoMed Uses Insects In Platform Technology

Nexia Completes Financing To Further Develop BioSteel

Germans, Chinese Report On Methods To Research DNA

Biota Follows Up Flu Drug With Effort In Common Cold

Cambridge Antibody Brings Another Product Into Clinic

Celltech Plans Further Studies Of Anti-TNF Drug In Arthritis

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.